Skip to main content
An official website of the United States government

autologous tumor-infiltrating lymphocytes HS-IT101

A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs HS-IT101 specifically recognize and kill the patient's tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous TILs HS-IT101
Code name:HS IT101
HS-IT101
HSIT101
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search